Purpose

The purpose of this two arm randomized clinical trial (RCT) is to test if a smoking cessation program called Quit for Life (QFL) which was developed by the investigators is effective for patients in China with HIV who smoke. This program is designed to suit the needs of people with HIV who smoke in China. Eligible participants who provide consent will be randomized into either the QFL or the Control group. The QFL group will receive a quit smoking program that lasts for 8 weeks with two parts- 1. 4 sessions with a trained counselor who will discuss the participants' smoking habits and strategies to help them quit. 2. Messages sent to the participants' cell phone using WeChat. The Control group will not have sessions with a trained counselor or receive messages sent to their cell phone. Both groups will be offered nicotine replacement therapy and a self-help guide with information about quitting smoking.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • HIV seropositive (by being at the HIV clinic and receiving care) - Receiving ART treatment from the clinic (by being at the HIV clinic and receiving care) - Smokes ≥ 5 cigarettes per day - Able to speak and read in Mandarin Chinese - Self-reported anticipate to receive ART treatment from the clinic for at least 9 months - Own a cell phone - Be willing to set a quit date within 1 month after baseline assessment

Exclusion Criteria

  • Self-reported using other smoking cessation program or medication - Having a serious health problem that may make them unsuitable to stay in the study

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary Purpose
Treatment
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Quit for Life group
Participants randomized to this arm will receive a 8 week quit smoking program delivered by trained counselors and messages to their cell phones. Participants will also be offered nicotine replacement therapy (gum or patch, depending on which one is available) and a self-help guide with information about quitting smoking.
  • Behavioral: Sessions with a trained counselor
    4 sessions will be provided with a trained counselor who will discuss the participant's' smoking habits with them and strategies to help them quit. The first session is in-person, lasts for 20 minutes, and typically happens when the participant comes to the HIV clinic to pick up their medication. Sessions 2 through 4 are over the telephone and last for 15 minutes each. These occur 1 week, 4 weeks, and 8 weeks after the first session.
  • Other: Cell phone messages
    Brief messages that give tips to help quit smoking will be sent to participants' cell phones using WeChat. 3 messages per day will be sent for the first week, 2 messages per day for the next 3 weeks, 1 message per day for the next 1 week, and 1-2 messages per week for the rest of the time
  • Other: Offered nicotine replacement therapy
    Participants will be offered nicotine replacement therapy (gum or patch, depending on which one is available).
  • Other: Self-help guide for quitting smoking
    Participants will be offered a self-help guide with information about quitting smoking.
Active Comparator
Control group
Participants randomized to this arm will be offered nicotine replacement therapy (gum or patch, depending on which one is available) and a self-help guide with information about quitting smoking.
  • Other: Offered nicotine replacement therapy
    Participants will be offered nicotine replacement therapy (gum or patch, depending on which one is available).
  • Other: Self-help guide for quitting smoking
    Participants will be offered a self-help guide with information about quitting smoking.

More Details

Status
Enrolling by invitation
Sponsor
Boston Medical Center

Study Contact

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.